WPI 3169 (Alendronate sodium 5 mg)

Pill imprint WPI 3169 has been identified as Alendronate sodium 5 mg.

Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alendronate sodium

Imprint:

WPI 3169

Strength:

5 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.